The company said the underwriters exercised in full their option to purchase 3,243,243 additional shares. The option was originally granted under the 21,621,622-share sale agreement with a 30-day term, as of May 28, 2025.

1. 01

   The company said the underwriters exercised in full their option to purchase 3,243,243 additional shares. The option was originally granted under the 21,621,622-share sale agreement with a 30-day term, as of May 28, 2025.

2. 02

   The company said the Forward Sellers expect to borrow an aggregate of 24,864,865 shares of common stock from third parties and sell them to the underwriters on May 29, 2025. The shares were registered on Form S-3 (Registration No. 333-272025).

3. 03

   The company said it may set the settlement date for each additional forward sale agreement at its discretion on or before February 25, 2027, and that the initial forward sale price is $36.26 per share. The price will be adjusted daily based on a floating interest rate factor equal to the overnight bank funding rate less a spread.

4. 04

   The company said it has the right to elect physical settlement, net share settlement or cash settlement, except in limited circumstances. It said a forward purchaser may require early physical settlement if certain events occur, such as being unable to hedge its exposure. The company also said physical settlement or net share settlement would dilute its earnings per share.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.